Evidence map›Paper›PMID 20926789›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma.

Qiaoling Liang, Lei Guo, Shaila Gogate, Zunayet Karim, Arezoo Hanifi, Donald Y Leung, Magdalena M Gorska, Rafeul Alam

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Allergic conjunctivitis renders CD4(+) T cells resistant to t regulatory cells and exacerbates corneal allograft rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2013
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Qiaoling LiangDivision of Allergy and Immunology, Department of Medicine and Pediatrics, National Jewish Health and University of Colorado at Denver, Denver, CO 80206, USA.
Lei Guo
Shaila Gogate
Zunayet Karim
Arezoo Hanifi
Donald Y Leung
Magdalena M Gorska
Rafeul Alam
University of Colorado Denver · USDenver Health Medical Center · USNational Jewish Health · US

Funding

Signaling Memory in Chronic AsthmaP01HL036577 · NHLBI · NATIONAL JEWISH HEALTH · PI GELFAND, ERWIN WILLIAM · 1986 to 2011
$18.7M
Role of MEK1 in T cell function in asthmaR01AI091614 · NIAID · NATIONAL JEWISH HEALTH · PI ALAM, RAFEUL · 2011 to 2015
$2.0M
The Role of Unc119 in T Cell Antigen Receptor Signaling1R01AI059719 · NIAID · NATIONAL JEWISH HEALTH · PI ALAM, RAFEUL · 2004 to 2008
$1.8M
The Importance of the p38 MAP Kinase Signaling Pathways in AsthmaR01AI068088 · NIAID · NATIONAL JEWISH HEALTH · PI ALAM, RAFEUL · 2005 to 2008
$1.5M
Mechanism of T Cell Resistance against Treg-mediated suppression in asthmaR56AI077535 · NIAID · NATIONAL JEWISH HEALTH · PI ALAM, RAFEUL · 2009 to 2010
$772k
NHLBI NIH HHS HL36577NHLBI NIH HHS P01 HL036577NIAID NIH HHS AI059719NIAID NIH HHS R01 AI059719NIAID NIH HHS R01 AI068088NIAID NIH HHS R01 AI091614NIAID NIH HHS R01 AI68088NIAID NIH HHS R56 AI077535
6 · The paper itself

Abstract

The T cell-driven airway inflammation in chronic asthma is uninhibited and sustained. We examined the resistance of T cells from asthmatic patients against suppression by TGF-β, IL-10 and glucocorticoids and explored its signaling mechanism. CD4(+)CD25(-) T cells from allergic asthmatic subjects demonstrated increased TCR-stimulated proliferation as compared with healthy and chronic obstructive pulmonary disease controls. This proliferation was resistant to inhibition by TGF-β, IL-10, and dexamethasone and to anergy induction. CD4 T cells from asthmatic patients, but not chronic obstructive pulmonary disease, allergic rhinitis, and healthy subjects, showed increased expression of MEK1, heightened phosphorylation of ERK1/2, and increased levels of c-Fos. IL-2 and IL-4 stimulated the expression of MEK1 and c-Fos and induced T cell resistance. The inhibition of MEK1 reversed, whereas induced expression of c-Fos and JunB promoted T cell resistance against TGF-β- and IL-10-mediated suppression. We have uncovered an IL-2- and IL-4-driven MEK1 induction mechanism that results in heightened ERK1/2 activation in asthmatic T cells and make them resistant to certain inhibitory mechanisms.

Indexed as

AdultAgedAsthmaCD4-Positive T-LymphocytesCell ProliferationCell SeparationClonal AnergyEnzyme-Linked Immunosorbent AssayFlow CytometryFluorescent Antibody TechniqueGene ExpressionGene Expression RegulationHumansInterleukin-10Interleukin-2Interleukin-4Interleukin-10Interleukin-2Interleukin-4MAP Kinase Kinase 1Transforming Growth Factor beta

Identifiers

PMID20926789
PMCPMC3367768
OpenAlexW1517175149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.